Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-08-31 Sale |
2020-09-02 4:34 pm |
BRISTOL MYERS SQUIBB CO | BMY | Caforio Giovanni Chairman and CEO |
39,840 | $62.7 | $2,497,968 | 445,584 (Direct) |
View |
2020-08-17 Sale |
2020-08-19 6:15 pm |
BRISTOL MYERS SQUIBB CO | BMY | Eid Joseph SVP,Head Glob. Medical Affairs |
5,327 | $64 | $340,928 | 2,534 (Direct) |
View |
2020-08-13 Sale |
2020-08-17 4:55 pm |
BRISTOL MYERS SQUIBB CO | BMY | LEUNG SANDRA EVP, General Counsel |
141,420 | $63.24 | $8,943,401 | 439,242 (Indirect Direct) |
View |
2020-07-09 Sale |
2020-07-13 6:27 pm |
ACCELERON PHARMA INC | XLRN | CELGENE CORP BRISTOL MYERS SQUIBB CO 10% Owner |
2,241 | $102.28 | $229,209 | 7,008,510 (Direct) |
View |
2020-07-01 Purchase |
2020-07-06 5:24 pm |
ACCELERON PHARMA INC | XLRN | CELGENE CORP BRISTOL MYERS SQUIBB CO 10% Owner |
108,108 | $92.5 | $9,999,990 | 6,971,772 (Direct) |
View |
2020-06-15 Purchase |
2020-06-16 5:15 pm |
BRISTOL MYERS SQUIBB CO | BMY | Paliwal Dinesh C Director |
9,174 | $54.5 | $499,983 | 22,109 (Direct) |
View |
2020-05-22 Sale |
2020-05-26 5:17 pm |
BRISTOL MYERS SQUIBB CO | BMY | Dubow Adam SVP,ChiefCompliance&EthicsOff. |
3,200 | $61.01 | $195,232 | 17,023 (Indirect Direct) |
View |
2020-05-19 Sale |
2020-05-21 5:22 pm |
BRISTOL MYERS SQUIBB CO | BMY | Schmukler Louis S EVP,Pres.,Glob.Prod. & Supply |
25,000 | $62.68 | $1,567,000 | 26,777 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2020-09-08 5:29 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Rice Derica W Director |
0 | $0 | 2,400 (Indirect) |
View |
2020-09-01 Option Award |
2020-09-02 4:33 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Price Paula A Director |
1,306 | $60.97 | 1,306 (Direct) |
View |
2020-09-01 Option Award |
2020-09-02 4:33 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Rice Derica W Director |
1,306 | $60.97 | 1,306 (Direct) |
View |
2020-09-01 Exercise |
2020-09-02 4:33 pm |
N/A 2020-09-01 |
BRISTOL MYERS SQUIBB CO | BMY | Santiago Karen Murphy SVP & Controller |
642 | $0 | 8,170 (Direct) |
View |
2020-09-01 Tax Withholding |
2020-09-02 4:33 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Santiago Karen Murphy SVP & Controller |
220 | $60.97 | 8,170 (Direct) |
View |
2020-08-01 Exercise |
2020-08-04 4:43 pm |
N/A 2021-08-01 |
BRISTOL MYERS SQUIBB CO | BMY | Elkins David V EVP, Chief Financial Officer |
46,402 | $0 | 101,380 (Direct) |
View |
2020-08-01 Tax Withholding |
2020-08-04 4:43 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Elkins David V EVP, Chief Financial Officer |
25,916 | $58.66 | 101,380 (Direct) |
View |
2020-07-09 Exercise |
2020-07-13 6:27 pm |
N/A N/A |
ACCELERON PHARMA INC | XLRN | CELGENE CORP BRISTOL MYERS SQUIBB CO 10% Owner |
38,979 | $5.88 | 7,008,510 (Direct) |
View |
2020-07-09 Exercise |
2020-07-13 6:27 pm |
N/A 2020-07-09 |
ACCELERON PHARMA INC | XLRN | CELGENE CORP BRISTOL MYERS SQUIBB CO 10% Owner |
38,979 | $0 | 7,008,510 (Direct) |
View |
2020-06-30 Option Award |
2020-07-02 5:15 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Samuels Theodore R. II Director |
553 | $58.8 | 20,049 (Direct) |
View |
2020-06-30 Option Award |
2020-07-02 5:14 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Storch Gerald L Director |
579 | $58.8 | 57,606 (Direct) |
View |
2020-06-30 Option Award |
2020-07-02 5:13 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Vousden Karen H Director |
165 | $58.8 | 14,077 (Direct) |
View |
2020-06-30 Option Award |
2020-07-02 5:11 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | YALE PHYLLIS R Director |
489 | $58.8 | 4,891 (Direct) |
View |
2020-06-30 Option Award |
2020-07-02 5:08 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | GROBSTEIN MICHAEL Director |
114 | $58.8 | 87,898 (Direct) |
View |
2020-06-30 Option Award |
2020-07-02 5:07 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Haller Julia A Director |
529 | $58.8 | 4,931 (Direct) |
View |
2020-06-30 Option Award |
2020-07-02 5:05 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | LACY ALAN J Director |
213 | $58.8 | 78,952 (Direct) |
View |
2020-06-30 Option Award |
2020-07-02 5:05 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Paliwal Dinesh C Director |
659 | $58.5 | 34,744 (Direct) |
View |
2020-06-30 Option Award |
2020-07-02 5:02 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Arduini Peter J Director |
616 | $58.8 | 26,664 (Direct) |
View |
2020-06-30 Option Award |
2020-07-02 5:00 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | BERTOLINI ROBERT J Director |
595 | $58.8 | 21,385 (Direct) |
View |
2020-06-30 Option Award |
2020-07-02 4:58 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | BONNEY MICHAEL W Director |
392 | $58.8 | 4,639 (Direct) |
View |
2020-06-30 Option Award |
2020-07-02 4:57 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Emmens Matthew Director |
616 | $58.8 | 21,668 (Direct) |
View |
2020-07-01 Exercise |
2020-07-02 4:56 pm |
N/A 2023-07-01 |
BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. |
9,356 | $0 | 32,962 (Direct) |
View |
2020-07-01 Tax Withholding |
2020-07-02 4:56 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. |
4,463 | $59.43 | 32,962 (Direct) |
View |
2020-07-01 Exercise |
2020-07-02 4:54 pm |
N/A 2023-07-01 |
BRISTOL MYERS SQUIBB CO | BMY | Santiago Karen Murphy SVP & Controller |
1,069 | $0 | 10,956 (Direct) |
View |
2020-07-01 Tax Withholding |
2020-07-02 4:54 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Santiago Karen Murphy SVP & Controller |
367 | $59.43 | 10,956 (Direct) |
View |
2020-06-13 Exercise |
2020-06-16 5:16 pm |
N/A 2021-06-13 |
BRISTOL MYERS SQUIBB CO | BMY | BONNEY MICHAEL W Director |
1,461 | $0 | 11,552 (Direct) |
View |
2020-06-13 Exercise |
2020-06-16 5:15 pm |
N/A 2021-06-13 |
BRISTOL MYERS SQUIBB CO | BMY | Haller Julia A Director |
1,461 | $0 | 7,721 (Direct) |
View |
2020-06-03 Tax Withholding |
2020-06-09 7:15 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | Eid Joseph SVP,Head Glob. Medical Affairs |
738 | $60.21 | 14,324 (Direct) |
View |
2020-06-03 Exercise |
2020-06-09 7:15 pm |
N/A 2023-06-03 |
BRISTOL MYERS SQUIBB CO | BMY | Eid Joseph SVP,Head Glob. Medical Affairs |
2,154 | $0 | 14,324 (Direct) |
View |
2020-06-03 Exercise |
2020-06-05 4:40 pm |
N/A 2022-06-03 |
BRISTOL MYERS SQUIBB CO | BMY | BONNEY MICHAEL W Director |
2,949 | $0 | 15,087 (Direct) |
View |
2020-06-03 Exercise |
2020-06-05 4:39 pm |
N/A 2022-06-03 |
BRISTOL MYERS SQUIBB CO | BMY | Haller Julia A Director |
2,949 | $0 | 11,256 (Direct) |
View |
2020-05-01 Tax Withholding |
2020-05-05 4:49 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | VESSEY RUPERT EVP, Research & Early Dev. |
5,274 | $60.26 | 54,389 (Direct) |
View |
2020-05-01 Exercise |
2020-05-05 4:49 pm |
N/A 2020-05-01 |
BRISTOL MYERS SQUIBB CO | BMY | VESSEY RUPERT EVP, Research & Early Dev. |
10,707 | $0 | 54,389 (Direct) |
View |
2020-05-01 Tax Withholding |
2020-05-05 4:49 pm |
N/A N/A |
BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology |
1,433 | $60.26 | 27,996 (Direct) |
View |
2020-05-01 Exercise |
2020-05-05 4:49 pm |
N/A 2020-05-01 |
BRISTOL MYERS SQUIBB CO | BMY | AHMED NADIM EVP and President, Hematology |
2,908 | $0 | 27,996 (Direct) |
View |